Thursday, December 8 at 12:30 PM ET
Apply by January 9: PA-16-414
SBIR and STTR Phase I grantees
are invited to join the Innovation Corps (I-Corps™) at NIH
program. Part of President Obama’s
Strategy for American Innovation, I-Corps™ at
NIH aims to support biomedical innovation and translation, with the
goal of expediting the development and commercialization of technologies that
address the leading causes of death and disability in the United
States. I-Corps™ participants will have dedicated time to focus on
translating ideas from the lab into a viable product on the market and help
avoid common failure points.
For more information or
questions on the I-Corps™ at NIH program, please visit NCI SBIR
Development Center, watch the archived webinar
from November, or contact:
Jennifer C. Shieh, PhD, jennifer.shieh@nih.gov
Small Business Coordinator, Office of Translational Alliances and Coordination,
NHLBI
Dates to remember:
January 9, 2017 – due date to apply to I‐Corps™
at NIH for Cohort 2, Phase I grant must be active
through at least June 9, 2017
April 23 - 26, 2017 – Course Kick-off (in person)
June 12 - 13, 2017 – Course Close-out/ Lessons Learned (in-person)
Tuesday December 13, 2 pm ET
Taking Care of Business: Managing SBIR/STTR Grants
Register HERE
Hear from NHLBI grants management staff experts about how to
speed up getting an NIH award; when you need to get approval from NIH &
when you don't; and common myths and misconceptions about the SBIR/STTR
grants process.
Andre Walker, BS
Grants Management Specialist, NHLBI
Jennifer Shieh, PhD
Small Business Coordinator, NHLBI
Friday December 16, 1 pm ET
Adopting New Technologies: A System’s Perspective
Register HERE
Panelists from MedStar Health, a $5B not-for-profit regional
healthcare system, will discuss the process by which a large system evaluates
new technologies and ultimately adopts them as part of their clinical arsenal,
to provide innovators with some insight into the barriers and hurdles they
should anticipate when creating their commercialization plans.
Neil J. Weissman, MD
President, MedStar Health Research Institute
Denise C. Noll, RN, CPHM, CMCN
Director, Institutional Contracting & Clinical Ops Support
MedStar Health Managed Care Operations
Ron Waksman, MD
Associate Director, Division of Cardiology
MedStar Heart Institute
Eric Padmore, MHSA
Scientific Program Analyst, NHLBI
If you haven’t participated in or watched one of our NHLBI
Small Biz Hangouts yet, you may be missing out. These webinars are
designed to help you understand aspects of product and company development that
you didn’t learn in school. Posted videos include:
Demystifying Small Business Review
Finding the Right Regulatory Consultant
Patent Litigation, Part 1 and Part 2
Check out the full YouTube playlist.
We are always interested in hearing what you would like to learn about or looking for presenters willing to share their knowledge, so contact us and be part of the NHLBI Small Biz Hangouts.
The NIH is seeking public input on a proposed new supplement
to facilitate participation of women and socially and economically
disadvantaged individuals in small businesses through the Small Business
Innovation Research (SBIR) and Small Business Technology Transfer (STTR)
programs. One of the goals of the SBIR/STTR programs is to foster and
encourage participation by socially and economically disadvantaged and
women-owned small businesses. Despite
SBIR/STTR awardees being eligible to apply for a diversity supplement under
the existing supplement program (see above), there are very low rates of
participation. The NIH has issued a Request for Information NOT-OD-17-008 to better understand
the barriers that prevent SBIR/STTR awardees from participating in the existing
diversity supplement program and to inform its consideration to develop a new
diversity supplement program specific to the SBIR/STTR mechanisms.
Notice number: NOT-OD-17-008
Responses:
If you would like to learn more about the RFI,
check the supplement notice (NOT-OD-17-008) or send your inquiries to
John Sheridan (john.sheridan@nih.gov).
Due by December 16, 2016, 11:59:59 PM EST
The National Heart Lung and Blood Institute (NHLBI) reminds all Program Directors/Principal Investigators (PD(s)/PI(s)) of SBIR/STTR awards that funds are available for administrative supplements to recruit and support high school, undergraduate, post-baccalaureate/post-master’s degree holders, and post-doctoral candidates that increase diversity in the research workforce.
PA-16-288 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)
PA-16-289 Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp)
These administrative supplements are designed to provide support for research experiences for individuals from the identified groups throughout the continuum from high school to the faculty level. In all cases, the proposed research experience must be an integral part of the approved, ongoing research of the parent award, and it must have the potential to contribute significantly to the research career development of the candidate. Supplement requests are considered on a rolling basis and must be submitted at least 3 months prior to the start date of the diversity candidate. So, if you are considering taking on a summer intern to start in May, you must submit your request no later than January 31.
More information about the NHLBI guidelines for the supplements may be viewed HERE
Please contact Jennifer Shieh (jennifer.shieh@nih.gov) if you are interested in applying for this supplemental funding and contributing to a more diverse research workforce.
If you decide not to participate, let us know why and help design something that works by responding to the Request for Information (NOT-OD-17-008)
One of the major goals of the
SBIR/STTR programs is to foster the participation of women-owned small
businesses (WOSB) and socially and economically disadvantaged (SDB) small
businesses. Your application is important! If you fall into either or both of
these categories, please be sure to check the appropriate box consistently.
This information is for reporting
purposes only – it will not be
evaluated during the peer review process.
What are women-owned small
businesses (WOSB) and Socially and Economically Disadvantaged (SDB) small
businesses?
WOSB:
- A firm must be at least 51% owned and controlled by one or more women, and primarily managed by one or more women (who must be US citizens).
- The firm must be "small" in its primary industry in accordance with the Small Business Administration (SBA)'s size standards for that industry.
- Small businesses self-certify on the SF424 (R&R) Form.
SDB:
- The firm must be 51% or more owned and control by one or more disadvantaged persons.
- The disadvantaged person or persons must be socially disadvantaged and economically disadvantaged.
- The firm must be small, according to SBA's size standards.
- Small businesses must self-certify by registering in the System for Award Management.
This information is used for federal tracking purposes ONLY and is encouraged, but not required. These metrics help the SBIR agencies coordinate targeted outreach to SDB and WOSB.
From more information, please visit: Women-Owned & Socially
and Economically Disadvantaged Businesses
The next NIH Small Business
Innovation Research (SBIR) and Small Business Technology Transfer (STTR)
application deadline is Thursday January 5, 2017, 5 pm local time.
The National Heart, Lung, and Blood Institute (NHLBI) welcomes all
investigator-initiated projects within our mission through the Omnibus funding
opportunities:
-
SBIR (PA-16-302) and STTR (PA-16-303) Omnibus Solicitations
for Phase I, Phase II, and Fast-Track applications
-
SBIR
Direct-to-Phase II
Pilot (PAR-14-088) for Direct to Phase II
applications (Last Receipt Date!).
Submit via ASSIST
ASSIST helps streamline the
electronic submission process. Try submitting with ASSIST before the January 5 deadline! Questions?
Use SBIR/STTR Application
Instructions, Forms Version D
Make sure you’re using “Forms Version D” SF424
SBIR/STTR Application Guide and Supplemental Grant Application Instructions
Find additional useful
resources from NIH SBIR
Contact the eRA Service Desk for electronic submission questions.
Toll-free: 1-866-504-9552
Phone: 301-402-7469
Hours: Mon-Fri, 7 a.m. to 8 p.m. Eastern Time (closed on federal
holidays)
Additional Funding
Opportunities Due in Winter 2017
-
January
5 – New Technologies for Viral Hepatitis (SBIR PA-15-077 STTR PA-15-076)
-
January
5 - Commercialization Readiness Pilot (CRP) Program:
Technical Assistance for Phase II Awardees - (SB1 PAR-16-026, Notice about NHLBI
participation NOT-HL-15-283)
View all NHLBI targeted funding opportunities on our
website (http://bit.ly/NHLBI-SBIR-FOA).
Note the change in application
receipt date for Stem Cell-Derived Blood Products for Therapeutic Use:
Technology Improvement (SBIR RFA-HL-15-030) – now due July 20 (Phase II
only) - NOT-HL-16-464
The NIH SBIR Direct to Phase
II Pilot Solicitation(s) and the Commercialization Readiness Pilot (CRP)
Program Solicitation(s) will stop accepting applications as the Congressional
authority to offer these pilots expire.
Last due date for the Omnibus Direct to Phase II
solicitation (PAR-14-088) is Jan 5, 2017.
Last due date for Commercialization Readiness Pilot (CRP) program (PAR-16-026, also see NHLBI Notice of Correction NOT-HL-15-283) is Apr 5, 2017.
01/09 - 01/11 – Biotech Showcase Conference 2017 -
San Francisco, CA
01/10 – The Redefining Early Stage Investments (RESI) Conference -
San Francisco, CA
02/13 - 02/14 – BIO CEO & Investor Conference -
New York, NY
|
